Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 48,835 | 20,653 | 25,186 | 26,353 | 48,257 |
| Cost of Goods | 3,726 | N/A | 1,142 | 2,297 | 1,368 |
| Gross Profit | 45,109 | 20,653 | 24,044 | 24,056 | 46,889 |
| Operating Expenses | 145,290 | 114,873 | 81,597 | 72,960 | 86,701 |
| Operating Income | -99,455 | -94,220 | -57,411 | -48,607 | -39,444 |
| Interest Expense | 11,892 | 9,176 | 8,565 | 6,487 | 5,200 |
| Other Income | 2,450 | 2,144 | 194 | -50 | 1,625 |
| Pre-tax Income | -108,897 | -101,252 | -65,782 | -55,144 | -43,019 |
| Net Income Continuous | -108,897 | -101,252 | -65,782 | -55,144 | -43,019 |
| Net Income | $-108,897 | $-101,252 | $-65,782 | $-55,144 | $-43,019 |
| EPS Basic Total Ops | -0.94 | -0.98 | -0.78 | -0.75 | -0.59 |
| EPS Basic Continuous Ops | -0.94 | -0.98 | -0.78 | -0.75 | -0.59 |
| EPS Diluted Total Ops | -0.94 | -0.98 | -0.78 | -0.75 | -0.59 |
| EPS Diluted Continuous Ops | -0.94 | -0.98 | -0.78 | -0.75 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.94 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-98,614 | $-92,455 | $-55,674 | $-47,043 | $-38,255 |